Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ehab Morsi

Pediatrics Riverview, MI Medical Doctor

NPI 1790781383 CMS profile 263257

14600 King Rd, Suite A, Riverview, MI 48193

Open in the dashboard

General payments

$3,077

196 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ehab Morsi of Riverview, MI is reported in the CMS Open Payments database as having received $3,077 across 196 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $415 22
2024 General $682 33
2023 General $696 47
2022 General $520 32
2021 General $332 20
2020 General $130 9
2019 General $303 33

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ehab Morsi
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Ehab Morsi were reported at $415. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Ehab Morsi Pediatrics median Middle half National median
2019 $303 $86 $31–$183 $163
2020 $130 $49 $22–$110 $114
2021 $332 $68 $27–$158 $132
2022 $520 $77 $30–$173 $149
2023 $696 $88 $33–$190 $160
2024 $682 $94 $34–$206 $164
2025 $415 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Pfizer Inc. $522 42 payments
  2. Tris Pharma Inc $439 23 payments
  3. Supernus Pharmaceuticals, Inc. $318 20 payments
  4. Corium, Inc. $298 24 payments
  5. GlaxoSmithKline, LLC. $285 18 payments
  6. Merck Sharp & Dohme Corporation $205 12 payments
  7. Sanofi Pasteur Inc. $198 11 payments
  8. Cranial Technologies, Inc $174 11 payments
  9. Ironshore Pharmaceuticals Inc. $135 7 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $90 6 payments
  11. Other $414 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,064 195 payments
  2. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. Azstarys $298 24 payments
  2. TRUMENBA $275 20 payments
  3. BEXSERO $272 17 payments
  4. COMIRNATY $256 14 payments
  5. Dyanavel XR Adhd $241 10 payments
  6. QELBREE $220 16 payments
  7. EUCRISA $203 15 payments
  8. Dyanavel XR Adhd $198 13 payments
  9. Doc Band $174 11 payments
  10. GARDASIL 9 $174 10 payments
  11. Other $2,430 146 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

196 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record